Ann: BIT225 RESTORES IMMUNE FUNCTION IN HIV-1 INFECTIONS, page-371

Totally agrre, and just a follow to your post Batmansdaughter, the paten published by BIT for bit036 sums it up in a few lines below, or click on the link and read all the details, even not understanding it all (like me) there is plenty in there to interpret as a huge positive for Biotron in it's quest to provide some sort of antiviral solution to Cvid-19.

Antiviral compounds and methods

WO EP US JP KR BR CA NZ US20190389816A1 Peter William Gage Biotron Limited

Priority 2003-06-26 • Filed 2019-08-29 • Published 2019-12-26

. Largest single opening events of a single channel. FIG. 8A-8C . Cinnamoylguanidine (Bit036) inhibits SARS E protein ion channel activity in NaCl solution. 8 A. Representative currents at holding potential of −40 mV. Scale bar is 300 mS and 5 pA. E protein ion channel activity and E protein channel …